head of
- MS Specialty Clinic and Research Unit Director
- School of Medicine Office of Research Sr. Associate Dean
- Contact Info
- 505-272-6950
- 505-272-3342
Ford, Corey Emeritus Professor of Neurology
Positions
- Professor, Department of Neurology , School of Medicine
- Vice-chair for Research, Neurology 2016 -
Corey C. Ford, MD, PhD is a Professor of Neurology and Sr. Associate Dean for Research. His area of clinical specialty is multiple sclerosis and neuroimmunology. He has participated in over 150 clinical trials of new treatments for MS. Other roles include Vice Chair for Research in the Department of Neurology, Director of the Regulatory Knowledge and Support component of our Clinical and Translational Science Center, and Director of the CTSC Pilot Funding program.
- Affiliation
- Publications
- Research
- Contact
- View All
Affiliation
clinical activities
- Multiple Sclerosis Specialty Clinic Director and physician provider
Publications
selected publications
-
academic article
- A parallelized strategy for epistasis analysis based on Empirical Bayesian Elastic Net models.. Bioinformatics (Oxford, England). 36:3803-3810. 2020
- Concurrent Local Delivery of Diflunisal Limits Bone Destruction but Fails To Improve Systemic Vancomycin Efficacy during Staphylococcus aureus Osteomyelitis.. Antimicrobial agents and chemotherapy. 64:-. 2020
- Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.. Neurology. 94:495-500. 2020
- StrainHub: a phylogenetic tool to construct pathogen transmission networks.. Bioinformatics (Oxford, England). 36:945-947. 2020
- Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.. JAMA neurology. :-. 2020
- Assessment of predicted enzymatic activity of α-N-acetylglucosaminidase variants of unknown significance for CAGI 2016.. Human mutation. 40:1519-1529. 2019
- Development and Psychometric Evaluation of a Community Program Capacity Scale for a Rural American Indian Tribe.. Journal of nursing measurement. 27:E95-E106. 2019
- Effect of Primary Care Parent-Targeted Interventions on Parent-Adolescent Communication About Sexual Behavior and Alcohol Use: A Randomized Clinical Trial.. JAMA network open. 2:-. 2019
- MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis.. PLoS pathogens. 15:-. 2019
- Radical Rebound Hydroxylation Versus H-Atom Transfer in Non-Heme Iron(III)-Hydroxo Complexes: Reactivity and Structural Differentiation.. Journal of the American Chemical Society. 141:6639-6650. 2019
- The role of resilience in healthcare transitions among adolescent kidney transplant recipients.. Pediatric transplantation. 23:-. 2019
- Interferon-gamma depresses human intestinal smooth muscle cell contractility: Relevance to inflammatory gut motility disturbances.. Life sciences. 222:69-77. 2019
- Adolescents Spending Time Alone With Pediatricians During Routine Visits: Perspectives of Parents in a Primary Care Clinic.. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 63:280-285. 2018
- New Skills to Reduce Sexual Risk Behaviors Among Young Adolescents.. Pediatrics. 141:-. 2018
- Talking with teens about traffic safety: Initial feasibility, acceptability, and efficacy of a parent-targeted intervention for primary care settings.. Journal of safety research. 66:113-120. 2018
- The Influence of Adolescence on Parents' Perspectives of Testing and Discussing Inherited Cancer Predisposition.. Journal of genetic counseling. :-. 2018
- Projecting the Adequacy of the Multiple Sclerosis Neurologist Workforce.. International journal of MS care. 20:35-43. 2018
- Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis.. Expert review of anti-infective therapy. 15:851-860. 2017
- Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome.. Journal of genetic counseling. 26:1106-1115. 2017
- Rapid Seafood Species Identification Using Chip-Based Capillary Electrophoresis and Protein Pattern Matching.. Journal of AOAC International. 100:1500-1510. 2017
- Cultivating the Multiple Sclerosis Workforce of the Future.. International journal of MS care. 19:123-130. 2017
- Parent and Adolescent Interest in Receiving Adolescent Health Communication Information From Primary Care Clinicians.. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 59:154-161. 2016
- The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.. Journal of neuroimaging : official journal of the American Society of Neuroimaging. :-. 2016
- Effectiveness of a Technology-Based Intervention to Teach Evidence-Based Practice: The EBR Tool.. Worldviews on evidence-based nursing. 13:59-65. 2016
- Changes in Young Adult Primary Care Under the Affordable Care Act.. American journal of public health. 105 Suppl 5:S680-S685. 2015
- Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.. Lancet neurology. :-. 2015
- Investigation of blast-induced traumatic brain injury.. Brain injury. 28:879-895. 2014
- Changes in intrinsic functional brain networks following blast-induced mild traumatic brain injury.. Brain injury. 27:1304-1310. 2013
- Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.. International journal of MS care. 14:105-114. 2012
- A baseline for the multivariate comparison of resting-state networks.. Frontiers in systems neuroscience. 5:-. 2011
- Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.. Multiple sclerosis (Houndmills, Basingstoke, England). 16:342-350. 2010
- Simulation of blast-induced early-time intracranial wave physics leading to traumatic brain injury.. Journal of biomechanical engineering. 131:-. 2009
- Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.. Annals of neurology. 61:14-24. 2007
- A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients.. Multiple sclerosis (Houndmills, Basingstoke, England). 12:309-320. 2006
- Glatiramer acetate therapy for multiple sclerosis: a review.. Expert opinion on drug metabolism & toxicology. 2:1019-1029. 2006
- Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data.. Acta neurologica Scandinavica. 111:42-47. 2005
- Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.. Neurology. 61:1367-1373. 2003
- Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial.. Multiple sclerosis (Houndmills, Basingstoke, England). 9:585-591. 2003
- The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.. The Journal of rheumatology. 29:1536-1542. 2002
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica.. Brain : a journal of neurology. 124:493-498. 2001
-
document
- Corrigendum to Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study [Journal of Stroke and Cerebrovascular Diseases Volume 28, Issue 2, February 2019, Pages 267-275].. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. -. 2019
Research
research overview
- The research efforts of the MS Specialty Clinic are centered on the search for new and better therapies for multiple sclerosis. Our clinical trials program has successfully performed over 25 studies, many leading to new, approved treatments for MS and extending the understanding of this difficult disease. The MS clinical and research program supports a team including two physicians, an advanced practice nurse, a nurse coordinator, a research coordinator, and several work study students. Other research interests are in magnetic resonance imaging applications to neurological diseases. Some current and recent research studies include stroke and vascular dementia, multiple sclerosis and systemic lupus. We are also engaged in a collaboration with Sandia National Laboratories on a project to simulate traumatic brain injury using high performance computing resources and computer impact modeling software programs.
other research activities
Contact
full name
- Corey C Ford